Rib Fractures and Death from Deletion of Osteoblast βcatenin in Adult Mice Is Rescued by Corticosteroids

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Duan, JinZhu ^a,c   Lee, Yueh ^a,b   Jania, Corey ^a,c   Gong, Jucheng ^a,c   Rojas, Mauricio ^a   Burk, Laurel ^b   Willis, Monte ^a   Homeister, Jonathon ^a   Tilley, Stephen ^a,c   Rubin, Janet ^a   Deb, Arjun ^a,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CORTICOSTEROID; DEXAMETHASONE; OSTEOCLAST DIFFERENTIATION FACTOR; PAMIDRONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; CAUSE OF DEATH; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; FEMALE; FLAIL CHEST; MALE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RESPIRATORY FAILURE; RIB FRACTURE; SURVIVAL RATE;

ADRENAL CORTEX HORMONES; ANIMALS; BETA CATENIN; DEXAMETHASONE; IMMUNOHISTOCHEMISTRY; MICE; OSTEOBLASTS; RIB FRACTURES;

EID: 84873491881     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055757     Document Type: Article

References (34)

1. Hu HL, Hilton MJ, Tu XL, Yu K, Ornitz DM, et al. (2005) Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132: 49-60.
2. Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C, (2005) Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 8: 727-738.
3. Day TF, Guo XZ, Garrett-Beal L, Yang YZ, (2005) Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8: 739-750.
4. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, et al. (2000) Inhibition of adipogenesis by Wnt signaling. Science 289: 950-953.
5. Kearns AE, Khosla S, Kostenuik PJ, (2008) Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev 29: 155-192.
6. Sawakami K, Robling AG, Ai M, Pitner ND, Liu D, et al. (2006) The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment. J Biol Chem 281: 23698-23711.
7. Case N, Rubin J, (2010) Beta-catenin-a supporting role in the skeleton. J Cell Biochem 110: 545-553.
8. Glass DA 2nd, Bialek P, Ahn JD, Starbuck M, Patel MS, et al (2005) Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8: 751-764.
9. Wuermser LA, Achenbach SJ, Amin S, Khosla S, Melton LJ 3rd (2011) What accounts for rib fractures in older adults? J Osteoporos 2011: 457591.
10. Barrett-Connor E, Nielson CM, Orwoll E, Bauer DC, Cauley JA, (2010) Epidemiology of rib fractures in older men: Osteoporotic Fractures in Men (MrOS) prospective cohort study. BMJ 340: c1069.
11. Lomauro A, Pochintesta S, Romei M, D'Angelo MG, Pedotti A, et al. (2012) Rib cage deformities alter respiratory muscle action and chest wall function in patients with severe osteogenesis imperfecta. PLoS ONE 7: e35965.
12. Roodman GD, (2009) Pathogenesis of myeloma bone disease. Leukemia 23: 435-441.
13. Kapoor M, Liu S, Shi-wen X, Huh K, McCann M, et al. (2008) GSK-3beta in mouse fibroblasts controls wound healing and fibrosis through an endothelin-1-dependent mechanism. J Clin Invest 118: 3279-3290.
14. Rousseau D, Suffia I, Ferrua B, Philip P, Le Fichoux Y, et al. (1998) Prolonged administration of dexamethasone induces limited reactivation of visceral leishmaniasis in chronically infected BALB/c mice. Eur Cytokine Netw 9: 655-661.
15. Spiro AS, Beil FT, Schinke T, Schilling AF, Eulenburg C, et al. (2010) Short-term application of dexamethasone enhances bone morphogenetic protein-7-induced ectopic bone formation in vivo. J Trauma 69: 1473-1480.
16. Weinstein RS, (2011) Clinical practice. Glucocorticoid-induced bone disease. N Engl J Med 365: 62-70.
17. Lovgren AK, Jania LA, Hartney JM, Parsons KK, Audoly LP, et al. (2006) COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 291: L144-156.
18. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, et al. (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 25: 1468-1486.
19. Cao G, Lee YZ, Peng R, Liu Z, Rajaram R, et al. (2009) A dynamic micro-CT scanner based on a carbon nanotube field emission x-ray source. Phys Med Biol 54: 2323-2340.
20. Zheng B, Zhang Z, Black CM, de Crombrugghe B, Denton CP, (2002) Ligand-dependent genetic recombination in fibroblasts: a potentially powerful technique for investigating gene function in fibrosis. Am J Pathol 160: 1609-1617.
21. Brault V, Moore R, Kutsch S, Ishibashi M, Rowitch DH, et al. (2001) Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 128: 1253-1264.
22. Whitaker M, Guo J, Kehoe T, Benson G, (2012) Bisphosphonates for osteoporosis-where do we go from here? N Engl J Med 366: 2048-2051.
23. Morony S, Warmington K, Adamu S, Asuncion F, Geng Z, et al. (2005) The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy. Endocrinology 146: 3235-3243.
24. Kim YH, Kim GS, Jeong-Hwa B, (2002) Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression. Exp Mol Med 34: 145-151.
25. Makrygiannakis D, af Klint E, Catrina SB, Botusan IR, Klareskog E, et al. (2006) Intraarticular corticosteroids decrease synovial RANKL expression in inflammatory arthritis. Arthritis Rheum 54: 1463-1472.
26. Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, et al. (2011) Matrix-embedded cells control osteoclast formation. Nat Med 17: 1235-1241.
27. Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, et al. (2011) Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med 17: 1231-1234.
28. Onal M, Xiong J, Chen X, Thostenson JD, Almeida M, et al. (2012) Receptor activator of nuclear factor kappaB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss. J Biological Chem 287: 29851-29860.
29. Yeo L, Toellner KM, Salmon M, Filer A, Buckley CD, et al. (2011) Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis. Ann Rheum Dis 70: 2022-2028.
30. Colucci S, Brunetti G, Cantatore FP, Oranger A, Mori G, et al. (2007) Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis. J Pathol 212: 47-55.
31. D OG, Ireland D, Bord S, Compston JE, (2004) Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts. Ann Rheum Dis 63: 354-359.
32. Humphrey EL, Williams JH, Davie MW, Marshall MJ, (2006) Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells. Bone 38: 652-661.
33. Matzelle MM, Gallant MA, Condon KW, Walsh NC, Manning CA, et al. (2012) Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway. Arthritis Rheum 64: 1540-1550.
34. Onishi T, Hayashi N, Theriault RL, Hortobagyi GN, Ueno NT, (2010) Future directions of bone-targeted therapy for metastatic breast cancer. Nat Rev Clin Oncol 7: 641-651.